Yu De-chao Michael - Net Worth and Insider Trading

Yu De-chao Michael Net Worth

The estimated net worth of Yu De-chao Michael is at least $11.4 Billion dollars as of 2025-07-22. Yu De-chao Michael is the 2101 Beneficial owner of Innovent Biologics Inc and owns about 129,695,998 shares of Innovent Biologics Inc (HKSE:01801) stock worth over $11.4 Billion. Details can be seen in Yu De-chao Michael's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yu De-chao Michael has not made any transactions after 2025-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Yu De-chao Michael

To

Yu De-chao Michael Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yu De-chao Michael owns 1 companies in total, including Innovent Biologics Inc (HKSE:01801) .

Click here to see the complete history of Yu De-chao Michael’s form 4 insider trades.

Insider Ownership Summary of Yu De-chao Michael

Ticker Company Transaction Date Type of Owner
HKSE:01801 Innovent Biologics Inc 2025-04-02 2101 Beneficial owner

Yu De-chao Michael Latest Holdings Summary

Yu De-chao Michael currently owns a total of 1 stock. Yu De-chao Michael owns 129,695,998 shares of Innovent Biologics Inc (HKSE:01801) as of March 28, 2025, with a value of $11.4 Billion.

Latest Holdings of Yu De-chao Michael

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01801 Innovent Biologics Inc 2025-03-28 129,695,998 87.60 11,361,369,425

Holding Weightings of Yu De-chao Michael


Yu De-chao Michael Form 4 Trading Tracker

According to the SEC Form 4 filings, Yu De-chao Michael has made a total of 14 transactions in Innovent Biologics Inc (HKSE:01801) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Innovent Biologics Inc is the sale of 3,726,000 shares on March 28, 2025, which brought Yu De-chao Michael around $0.

Insider Trading History of Yu De-chao Michael

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yu De-chao Michael Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Yu De-chao Michael Ownership Network

Ownership Network List of Yu De-chao Michael

No Data

Ownership Network Relation of Yu De-chao Michael

Insider Network Chart


Yu De-chao Michael Owned Company Details

What does Innovent Biologics Inc do?

Who are the key executives at Innovent Biologics Inc?

Yu De-chao Michael is the 2101 Beneficial owner of Innovent Biologics Inc. Other key executives at Innovent Biologics Inc include 2201 Interest of corporation controlled by you BlackRock, Inc. , Temasek Holdings (private) Limited , and 2502 Approved lending agent JPMorgan Chase & Co. .

Innovent Biologics Inc (HKSE:01801) Insider Trades Summary

Over the past 18 months, Yu De-chao Michael made 8 insider transaction in Innovent Biologics Inc (HKSE:01801) with a net sale of 2,406,250. Other recent insider transactions involving Innovent Biologics Inc (HKSE:01801) include a net purchase of 4,736,374 shares made by JPMorgan Chase & Co. , a net sale of 6,533,500 shares made by Temasek Holdings (private) Limited , and a net sale of 0 shares made by BlackRock, Inc. .

In summary, during the past 3 months, insiders sold 3,048,500 shares of Innovent Biologics Inc (HKSE:01801) in total and bought 0 shares, with a net sale of 3,048,500 shares. During the past 18 months, 15,297,155 shares of Innovent Biologics Inc (HKSE:01801) were sold and 6,881,150 shares were bought by its insiders, resulting in a net sale of 8,416,005 shares.

Innovent Biologics Inc (HKSE:01801)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Innovent Biologics Inc Insider Transactions

No Available Data

Yu De-chao Michael Mailing Address

Above is the net worth, insider trading, and ownership report for Yu De-chao Michael. Currently GuruFocus does not have mailing address information for Yu De-chao Michael.